Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002307 · ClinicalTrials.gov registry record · NA
A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
A NA study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- NA
- Development phase
NCT00002307: Completed NA study, sponsored by Bristol-Myers Squibb.
NCT00002307 is a NA study that has completed, run by Bristol-Myers Squibb. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002307, a NA study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To compare stavudine (d4T) and zidovudine (AZT) in slowing the progression of HIV disease. To compare the antiviral activity of d4T versus AZT as measured by plasma levels of p24 antigen and HIV viremia, and their relative efficacy by improvement and/or absence of adverse changes over time in laboratory parameters associated with HIV infection. To compare the safety of oral doses of d4T to AZT in patients with HIV infection.
Interventions
- DRUG Zidovudine
- DRUG Stavudine
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 1994-12 |
| Phase | NA |
What the finished NCT00002307 record still lists
NCT00002307 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Zidovudine is the first listed.
NCT00002307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002307 about?
NCT00002307 is a clinical study titled "A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients". To compare stavudine (d4T) and zidovudine (AZT) in slowing the progression of HIV disease. To compare the antiviral activity of d4T versus AZT as measured by plasma levels of p24 antigen and HIV viremia, and their relative efficacy by improvement and/or absence of adverse changes over time in labora...
What is the current status of trial NCT00002307?
This trial is currently completed. It is a NA study. Estimated completion is 1994-12.
What interventions are being tested in trial NCT00002307?
The interventions under investigation include: Zidovudine (DRUG), Stavudine (DRUG).
Who is sponsoring clinical trial NCT00002307?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.